2006
DOI: 10.1016/s0020-7292(06)60029-5
|View full text |Cite
|
Sign up to set email alerts
|

Carcinoma of the Vagina

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
23
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(24 citation statements)
references
References 0 publications
1
23
0
Order By: Relevance
“…Primary carcinoma of the vagina (PCV) is a rare malignancy, comprising only 1–2% of the malignancies of the female genital tract (Beller et al , 2006). The most prevalent histological type of PCV is squamous cell carcinoma (SCC).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Primary carcinoma of the vagina (PCV) is a rare malignancy, comprising only 1–2% of the malignancies of the female genital tract (Beller et al , 2006). The most prevalent histological type of PCV is squamous cell carcinoma (SCC).…”
mentioning
confidence: 99%
“…The most prevalent histological type of PCV is squamous cell carcinoma (SCC). Primary carcinoma of the vagina mostly affects women over 60 years of age and has a poor prognosis (Beller et al , 2006; Hellman et al , 2006). Due to its rarity, biological and prognostic factors of PCV have not been frequently studied, in contrast to other malignancies of the female genital tract.…”
mentioning
confidence: 99%
“…[8] Primary invasive carcinoma of the vagina is predominantly a disease of elderly women; 70-80% of cases are diagnosed in women older than 60 years. [9] Human papillomavirus (HPV) infection is one of the etiology for vaginal cancer with prevalence rate of 60-65%. [10] HPV-induced vaginal lesions are thought to arise in areas of squamous metaplasia that develop during healing of mucosal abrasions caused by coitus, tampon use, chronic pessary use, or other trauma.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 The overall 5-year survival rates have risen by 15% over a 40-year period, primarily due to earlier diagnosis and the advances in irradiation techniques. 3,4 Surgical excision has been advocated only in patients with early disease presenting with small lesions. Radiation therapy is generally recommended when a curative surgical approach is not technically feasible or when surgery would risk major compromise of bladder, bowel, or vaginal function.…”
Section: Introductionmentioning
confidence: 99%
“…[5][6][7] However, 5-year survival in advanced stages is still poor, being 52.2% for patients with stage II, 42.5% for patients with stage III, and 20.5% for patients with stage IVA disease. 4 Recently, concurrent chemoradiation therapy (CCRT) has been found To yield superior survival in patients with locally advanced vaginal carcinoma (stages II to IVA) and it has therefore been considered as primary treatment for such patients. 8 We present a treatment alternative to traditional radiation therapy in the nonsurgical management of vaginal cancer and review our experience with patients with primary squamous cell carcinoma of the vagina who received CCRT.…”
Section: Introductionmentioning
confidence: 99%